Leadership & Management
The triple squeeze on leaders and a messy middle: New future of work report

At a time where the healthcare and life sciences sector is being pushed to reinvent itself, Vanessa Meikle, CEO and Founder of Hunton Executive, delves into the driving force behind a new report: The Future of Work in Healthcare & Life Sciences.
In this candid and reflective podcast, leaders are challenged to re-examine their own assumptions about leadership, workplaces, and the fast-changing dynamics within the sector. Meikle paints an intriguing picture of the complex ecosystem leaders are currently facing that goes far beyond navigating uncertainty.
She reveals key themes from the report including the “triple squeeze” and “messy middle” – not as trends to watch, but as seismic shifts rewriting the rules of leadership and workplace dynamics. She points to one insight in particular that is likely to make leaders uncomfortable.
The report also prompts Meikle to reflect on her own assumptions and biases, especially in relation to artificial intelligence (AI) and the future of work. The findings disrupt familiar thinking, revealing just how easily ingrained ideas can go unchallenged.
If this survey is repeated in two years from now, will leadership and workplaces be a mirror reflecting real change or a mask hiding the status quo?
In reimagining healthcare across the entire patient journey, Health Industry HubTM is the only one-stop-hub uniting the diversity of the Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change.
The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.
News - MedTech & Diagnostics

What will it take to code genomics into the heart of healthcare?
As Australia stands at a crossroads in integrating genomics into the fabric of its healthcare system, Dr Erin Evans, CEO […]
MoreNews - Pharmaceuticals

HTA Review IAG nears key milestones
The Health Technology Assessment (HTA) Review Implementation Advisory Group (IAG) is gearing up to deliver its interim report to Federal […]
MoreNews - Pharmaceuticals

Harsh reality of shrinking PBS investment amid U.S. pressure to raise medicines pricing
A growing number of Australians are voicing concerns about access to innovative medicines, with new research from AbbVie Australia revealing […]
MoreNews - Pharmaceuticals

New PBS listing in melanoma flips ‘surgery then drugs’ rationale on its head
From 1 August, Australians diagnosed with high-risk stage III melanoma have access to neoadjuvant combination immunotherapy through the Pharmaceutical Benefits […]
More